Initiation and regulation of CNS autoimmunity.

Department of Molecular Biotechnology, University of Washington, Seattle 98195, USA.
Critical Reviews in Immunology (Impact Factor: 3.89). 02/1997; 17(5-6):469-80.
Source: PubMed

ABSTRACT Our studies addressed the questions of how self-reactive T cells escape tolerance and what stimuli cause these T cells to initiate autoimmune responses. We employed experimental allergic encephalomyelitis (EAE) as an animal model of multiple sclerosis (MS). Endogenous expression of myelin basic protein (MBP) induces tolerance in T cells that recognize one region of MBP, whereas T cells specific for a different region escape tolerance. Triggers of disease induction were investigated in a T-cell receptor (TCR) transgenic model in which the majority of T cells recognize the MBP epitope that does not induce tolerance. EAE occurs spontaneously in this model and the incidence of disease depends on microbial exposure. EAE can also be actively induced by immunization with MBP peptide accompanied by injection of pertussis toxin as well as by administration of pertussis toxin alone. Immunization with MBP peptide without pertussis toxin, however, stimulates the transgenic T cells, but the activated T cells do not accumulate in the central nervous system (CNS) or induce EAE. Our studies suggest that initiation of autoimmune disease involves complex interactions between the neuroendocrine system as well as the innate and specific immune systems.

  • [Show abstract] [Hide abstract]
    ABSTRACT: By means of immunohistochemical staining, cells actively infected with human herpesvirus 6 (HHV-6) were found in central nervous system tissues from 8 (73%) of 11 patients with definite multiple sclerosis (MS). Interestingly, 17 (90%) of 19 tissue sections showing active demyelination were positive for HHV-6-infected cells compared with only 3 (13%) of 23 tissue sections free of active disease (P<.0001). Central nervous system tissues from 2 of 28 normal persons and patients with other inflammatory demyelinative diseases were positive for HHV-6-infected cells (P<.0001), and the 2 positive cases were diagnosed as having HHV-6 leukoencephalitis. By use of a rapid culture assay, blood samples from 22 (54%) of 41 patients with definite MS were found to contain active HHV-6 infections, compared with 0 of 61 normal controls (P<.0001). No significant difference was found between HHV-6 viremia-positive and HHV-6 viremia-negative MS patients with respect to type of disease (relapsing/remitting or progressive). In contrast, patients with active HHV-6 viremia were significantly younger and had shorter durations of disease than did HHV-6 viremia-negative patients.
    Clinical Infectious Diseases 11/2000; 31(4):894-903. DOI:10.1086/318141 · 9.42 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently developed B6.kappa(-)lambda(SEG) mice (by crossing kappa(-) and C57BL/6 mice congenic for the wild Mus spretus SEG strain lambda locus lacking genes coding for lambda1 and lambda3) have a very reduced light chain diversity. B6.kappa(-)lambda(SEG) mice produce only lambda2 and lambdax light chains. Regardless of their Igh haplotype, B6.kappa(-)lambda(SEG) mice show a restricted B cell distribution by light chain subtype with lambdax dominance in all peripheral compartments except peritoneal cavity where lambda2 is dominant. This distribution suggests that selection mechanisms act differently in different B cell compartments on lambda2 and lambdax bearing B cells. Sequence analysis before or following immunization did not reveal unusual mechanisms of diversification. B6.kappa(-)lambda(SEG) mice still respond to various challenging antigens using new Ab patterns. In particular, regardless of Igh(a) or Igh(b) haplotypes, the anti-2,4-dinitrophenyl response is characterized by a restricted diversity for both heavy and light chains and a delayed IgG response when compared to B6 and B6.kappa(-) mice. We suggest that the delayed IgG response is due to the expansion of marginal zone B cells whereas follicular B cells are strongly reduced.
    European Journal of Immunology 11/2004; 34(10):2812-23. DOI:10.1002/eji.200324396 · 4.52 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Immunological privilege of the central nervous system (CNS) has often been viewed as the summation of mechanisms that are protective of, but extrinsic to, the CNS. Their primary role has then been seen as isolating the CNS from the organism as a whole. Experiments in recent years indicate that the CNS itself may have an innate immune system comprised of astrocytes and microglia capable of regulating the initiation and progression of immune responses. Thus, immunological privilege should be considered as an intrinsic property of the CNS that could involve direct CNS:immune cell interactions. Malfunctions of these intrinsic mechanisms could play significant roles augmenting or even initiating CNS-directed autoimmunity and inflammation. J. Neurosci. Res. 55:1–8, 1999. © 1999 Wiley-Liss, Inc.
    Journal of Neuroscience Research 01/1999; 55(1):1 - 8. DOI:10.1002/(SICI)1097-4547(19990101)55:1<1::AID-JNR1>3.0.CO;2-9 · 2.73 Impact Factor